Bis[2-(4-aminopiperidin-1-yl)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-4-hydroxypyrrolidin-1-yl]methanone
C37H54N8O3 — CID 175916242
Data last refreshed: (MolForge compound catalog, from PubChem)
About Bis[2-(4-aminopiperidin-1-yl)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-4-hydroxypyrrolidin-1-yl]methanone
Bis[2-(4-aminopiperidin-1-yl)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-4-hydroxypyrrolidin-1-yl]methanone (PubChem CID 175916242) has the molecular formula C37H54N8O3 and a molecular weight of 658.89 g/mol. Its IUPAC name is bis[2-(4-aminopiperidin-1-yl)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-4-hydroxypyrrolidin-1-yl]methanone.
Molecular Properties
| Compound Name | Bis[2-(4-aminopiperidin-1-yl)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-4-hydroxypyrrolidin-1-yl]methanone |
|---|---|
| PubChem CID | 175916242 |
| Molecular Formula | C37H54N8O3 |
| Molecular Weight | 658.89 g/mol |
| Exact Mass | 658.43 |
| IUPAC Name | bis[2-(4-aminopiperidin-1-yl)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-4-hydroxypyrrolidin-1-yl]methanone |
| SMILES | NC1CCN(C2C(N3CCc4ccccc4C3)C(O)CN2C(=O)N2CC(O)C(N3CCc4ccccc4C3)C2N2CCC(N)CC2)CC1 |
| InChI | InChI=1S/C37H54N8O3/c38-29-11-17-40(18-12-29)35-33(42-15-9-25-5-1-3-7-27(25)21-42)31(46)23-44(35)37(48)45-24-32(47)34(36(45)41-19-13-30(39)14-20-41)43-16-10-26-6-2-4-8-28(26)22-43/h1-8,29-36,46-47H,9-24,38-39H2 |
| InChIKey | KQCYSPUKPTXVCP-UHFFFAOYSA-N |
| XLogP | 0.81 |
| TPSA | 129.01 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 48 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 658.89 |
| LogP ≤ 5 | 0.81 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175916242 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.